Total Payments
$985.08
2024 Payments
$564.80
Companies
16
Transactions
52
Medicare Patients
638
Medicare Billing
$59,919
Payment Breakdown by Category
Food & Beverage$985.08 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $985.08 | 52 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $239.92 | 13 | $0 (2024) |
| Novo Nordisk Inc | $160.98 | 10 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $114.29 | 6 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $92.21 | 4 | $0 (2024) |
| GlaxoSmithKline, LLC. | $70.83 | 4 | $0 (2024) |
| Shield Therapeutics Inc | $56.95 | 1 | $0 (2023) |
| Exact Sciences Corporation | $50.30 | 3 | $0 (2024) |
| Dexcom, Inc. | $48.76 | 2 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $27.91 | 2 | $0 (2023) |
| Astellas Pharma US Inc | $22.58 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $564.80 | 30 | Lilly USA, LLC ($169.35) |
| 2023 | $328.26 | 17 | Shield Therapeutics Inc ($56.95) |
| 2022 | $92.02 | 5 | Novo Nordisk Inc ($54.03) |
All Payment Transactions
52 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: VACCINE | ||||||
| 11/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: DIABETES | ||||||
| 11/06/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: Biological | ||||||
| 11/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: RESPIRATORY | ||||||
| 10/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Obesity | ||||||
| 10/04/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.80 | General |
| 10/01/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Diabetes | ||||||
| 09/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: RESPIRATORY | ||||||
| 09/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Respiratory | ||||||
| 08/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN, TRULANCE | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Gastroenterology | ||||||
| 08/20/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $25.14 | General |
| Category: DIABETES | ||||||
| 07/23/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: Diabetes | ||||||
| 07/09/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.96 | General |
| 06/21/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/12/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Diabetes | ||||||
| 05/16/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Oncology | ||||||
| 05/02/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Diabetes | ||||||
| 04/27/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: Endocrinology | ||||||
| 04/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Respiratory | ||||||
| 04/10/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Diabetes | ||||||
| 04/10/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Obesity | ||||||
| 03/15/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 328 | 476 | $136,269 | $31,898 |
| 2022 | 10 | 285 | 379 | $108,465 | $25,110 |
| 2021 | 1 | 25 | 29 | $10,822 | $2,911 |
Total Patients
638
Total Services
884
Medicare Billing
$59,919
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 100 | 229 | $88,616 | $18,959 | 21.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 33 | 33 | $12,573 | $4,207 | 33.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 27 | 30 | $10,500 | $2,138 | 20.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 12 | 12 | $6,003 | $1,956 | 32.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $8,064 | $1,422 | 17.6% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 40 | 40 | $3,106 | $1,023 | 32.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 19 | $5,193 | $1,003 | 19.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 28 | 31 | $1,240 | $946.12 | 76.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 12 | 12 | $542.00 | $125.73 | 23.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 43 | 54 | $432.00 | $118.80 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 84 | 164 | $64,054 | $13,429 | 21.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 28 | 28 | $9,408 | $3,630 | 38.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 15 | 19 | $10,393 | $2,660 | 25.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 27 | 27 | $9,084 | $1,844 | 20.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $7,605 | $1,293 | 17.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 29 | 29 | $1,160 | $853.80 | 73.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 14 | 15 | $4,077 | $648.46 | 15.9% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2022 | 19 | 19 | $1,330 | $493.24 | 37.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 17 | 17 | $986.00 | $158.85 | 16.1% |
| 81003 | Automated urinalysis test | Office | 2022 | 37 | 46 | $368.00 | $99.61 | 27.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 25 | 29 | $10,822 | $2,911 | 26.9% |
About Dr. Jia Wen Lee, DO
Dr. Jia Wen Lee, DO is a Internal Medicine healthcare provider based in Dacula, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/18/2018. The National Provider Identifier (NPI) number assigned to this provider is 1730673328.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jia Wen Lee, DO has received a total of $985.08 in payments from pharmaceutical and medical device companies, with $564.80 received in 2024. These payments were reported across 52 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($985.08).
As a Medicare-enrolled provider, Lee has provided services to 638 Medicare beneficiaries, totaling 884 services with total Medicare billing of $59,919. Data is available for 3 years (2021–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Dacula, GA
- Active Since 06/18/2018
- Last Updated 07/27/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1730673328
Products in Payments
- MOUNJARO (Drug) $170.26
- JARDIANCE (Drug) $85.43
- ACCRUFER (Drug) $56.95
- Cologuard Collection Kit (Device) $50.30
- Dexcom G6 Transmitter (Medical Supply) $48.76
- BREZTRI (Drug) $38.77
- FARXIGA (Drug) $37.98
- AIRSUPRA (Drug) $37.54
- ZEPBOUND (Drug) $35.05
- TRELEGY ELLIPTA (Drug) $34.90
- Rybelsus (Drug) $33.06
- QUVIVIQ (Drug) $27.91
- SYNJARDY (Drug) $25.14
- Veozah (Drug) $22.58
- NEXLETOL (Drug) $21.62
- SHINGRIX (Biological) $19.08
- PAXLOVID (Drug) $17.64
- AREXVY (Drug) $16.85
- Otezla (Drug) $16.53
- EMGALITY (Drug) $16.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Dacula
Dr. Rachel Nisbet, M.d, M.D
Internal Medicine — Payments: $9,899
Internal Medicine $9,899
Dr. Holly Corley, M.d, M.D
Internal Medicine — Payments: $9,265
Internal Medicine $9,265
Dr. Rami Arfoosh, M.d, M.D
Internal Medicine — Payments: $9,167
Internal Medicine $9,167
Dr. Shashvat Sukhal, M.d, M.D
Internal Medicine — Payments: $5,527
Internal Medicine $5,527
Dr. Daren Wannamaker, Do, DO
Internal Medicine — Payments: $1,456
Internal Medicine $1,456
Zhuocheng Su, Do, DO
Internal Medicine — Payments: $1,382
Internal Medicine $1,382